<DOC>
	<DOCNO>NCT01240382</DOCNO>
	<brief_summary>To investigate efficacy 3 % DE-089 ophthalmic solution ( one drop time , 6 time daily , 4 week topical administration ) , comparison 0.1 % sodium hyaluronate ophthalmic solution ( 0.1 % HA ) ( one drop time , 6 time daily , 4 week topical administration ) , least non-inferior change fluorescein stain score , superior change Rose bengal score , multicenter , double-masked , parallel-group comparison study . Safety profile likewise compare .</brief_summary>
	<brief_title>Phase III Confirmatory Study DE-089 Ophthalmic Solution Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Those show : Keratoconjunctival disorder confirm vital dye stain Abnormal Schirmer score result Eye disease need therapy dry eye Those need wear contact lenses clinical study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>